Idéal Investisseur
Newsletter Idéal Investisseur NEWSLETTER
Magazine Idéal Investisseur MAGAZINE
Reset password
Idéal Investisseur
SBF 120 :
6 261,75 pts
+0.41%


Last update : 06/02/2026 - 17h38
Best-performing stocks :
APERAM
+11,80%
VINCI
+9,91%
EIFFAGE
+5,71%
SPIE
+5,13%
SOITEC
+4,80%
Least-performing stocks :
STELLANTIS NV
-25,24%
AYVENS
-6,73%
ATOS
-5,49%
Vusion
-4,61%
DANONE
-3,70%
Annonce
Linxea 300x600




Stock
VALNEVA
FR0004056851

Short-term technical trend
Bearish
Moving Average Trend
=
4,03 €
Last update 06/02/2026 à 17:35:14
-1,27 %
Since the previous close


+8,34 %

Since january 1st


-38,50 %

3 years evolution


Tendance technique CT
Bearish
Tendance Moyennes Mobiles
=

Stock data: VALNEVA

Higher 4,08 € Lower 3,94 €
Open 4,03 € Previous close 4,08 €
Volume626 938 Traded value 2 494 929,52 €
Capitalisation / nb of shares 693 675 950 € /
172 213 493 		Capital turnover 0,36 %
Sector Industrie Pharmaceutique et Biotechnologie main indices SBF 120, CAC ALL-TRADABLE
Market Euronext PARIS Eligible (France): PEA SRD
Annonce
Assurance vie

Stock price movement

06/02/2026 à 17:35:14

Technical analysis VALNEVA

50-day moving average3,95 € Pivot 4,01 €
Support 3,61 € -10.38 %
Résistance 4,43 € +9.98 %
1-month volatility 15,51 % Annualized volatility 65,92 %
RSI (14d)Neutral (41) Stochastic signal (14d) Neutre
ATR (14d)Low volatility (0,13) CMF (21d)Slightly bullish (0,08)
Bollinger (20d)Neutral OBV (21d) OBV data unavailable

Performance history

Since January 1st, the share price of VALNEVA has risen by 8,34%. Over three years, the stock has declined by -38,50%. Over the past 12 months, VALNEVA has recorded an increase of 8.34%. In the medium term, the stock has shown a rise of 8.34% over the last three months. The share has been slightly volatile over the past rolling quarter. Considering the same periods, VALNEVA has fluctuated by as much as % over the last three months and % over the past twelve months.

Please note: these indicators are for informational purposes only and do not guarantee future results. Past performance is not indicative of future performance.

Share price performance of VALNEVA over various periods:

Perf Higher Lower
1 week+0,95%4,33,84
1 month+6,90%4,493,64
3 months+4,08%4,493,46
6 months+19,67%5,43,30
12 months+30,36%5,42,25
3 years-38,50%7,851,73
5 years-71,67%29,701,73
Since IPO-46,36%29,701,73
The information provided in this document is for informational purposes only and should not be considered investment advice. Past performance is no guarantee of future returns. This product carries a risk of capital loss.

Relatited articles about VALNEVA






News

04/02 Valneva's Stock Rises Following Oddo BHF's Target Upgrade
03/02 Valneva and Instituto Butantan Launch Pilot Vaccination Campaign Against Chikungunya in Brazil
31/01 Valneva Stock Drops Over 11% Over the Week
28/01 Valneva Stock Drops 2.45% at Close, Falls Below its 20-Day Moving Average
26/01 Valneva Shares Drop 6.38% Midday Monday
22/01 Valneva Rebounds at Close After IXCHIQ Withdrawal in the US
21/01 Valneva Shares Dip Midday After U.S. Withdrawal
20/01 Valneva Shares Bounce Back at Close Despite IXCHIQ Withdrawal
19/01 Valneva Shares Drop 5.65% at Midday, RSI Reaches Overbought Territory
19/01 Valneva Withdraws U.S. Authorization Requests for Its Chikungunya Vaccine
16/01 Valneva Stock Continues its Rebound, Closing at 4.39 Euros
15/01 Valneva Shares Drop 3.7% Amid Profit-Taking
09/01 Valneva Presents its Outlook at the J.P. Morgan Healthcare Conference
07/01 Valneva Stock Down 2.63% Midday After Yesterday's Surge
06/01 Valneva's Stock Soars 6.53% Midday After Stifel's Target Upgrade
29/12 Valneva Stock Rises 2.83% at Midday This Monday, December 29
22/12 Valneva's Stock Rises 3.14% at Close, Driven by Technical Interest Ahead of Crucial Phase 3 Results
11/12 Valneva's Stock Rises 3.8% Midday Thursday, Boosted by Bullish VLA15 Profile
11/12 Valneva Confirms Positive Results of Its Chikungunya Vaccine in Children
28/11 Valneva Shares Fall 5.44% Midday After Previous Day's Surge

Industry data

Sector CAC40 performance (%) Euronext performance (%)
Health Care -1.12% -1.33%
Pharmaceuticals & Biotechnology -0.90% -1.45%
Pharmaceuticals -0.90% -1.23%

Indice Pts Performance (%)
SBF 120 6261.75 +0.41%

SBF 120 data

Name Price (€) Perf.(%)
Best-performing stocks
Least-performing stocks




WARNINGS: The information presented here is based on data published by third-party information providers. It is not contractual and carries no guarantee of accuracy. It should not be considered as investment advice. Ideal-investisseur.fr cannot be held responsible for any potential damages or losses arising from the use of this information.





About
Advertisers
Privacy policy


Contact
Legal notice



The content of this site does not constitute investment advice or a recommendation in any way. Investing in markets or any investment product is risky. You should ensure that you can afford to lose all or part of your capital.
© 2025 - ideal-investisseur.fr